
Sign up to save your podcasts
Or


The editors also review two recently licensed drugs: eluxadoline, a mixed opioid receptor agonist/antagonist for irritable bowel syndrome (http://dtb.bmj.com/content/55/8/90) and an oral formulation of glycopyrronium (http://dtb.bmj.com/content/55/8/93) for severe drooling in children.
By BMJ Group4.8
44 ratings
The editors also review two recently licensed drugs: eluxadoline, a mixed opioid receptor agonist/antagonist for irritable bowel syndrome (http://dtb.bmj.com/content/55/8/90) and an oral formulation of glycopyrronium (http://dtb.bmj.com/content/55/8/93) for severe drooling in children.

1,090 Listeners

891 Listeners

219 Listeners

2,120 Listeners

1,981 Listeners

37 Listeners

48 Listeners

90 Listeners

7 Listeners

5 Listeners

3 Listeners

1 Listeners

3 Listeners

10 Listeners

40 Listeners

14 Listeners

1 Listeners

51 Listeners

0 Listeners

6 Listeners

17 Listeners

17 Listeners

3 Listeners

20 Listeners

1,138 Listeners

23 Listeners

6 Listeners

18 Listeners

165 Listeners

2,841 Listeners

2,072 Listeners

837 Listeners

4 Listeners

0 Listeners